| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 10/19/1994 | EP0619742A1 Transfection of lung via aerosolized transgene delivery |
| 10/19/1994 | EP0619738A1 Inhibitory immunoglobulin polypeptides to human pdgf beta receptor |
| 10/19/1994 | CN1093751A Isolated nucleic acid molecules coding for tumor rejection antigen precursor MAGE-3 and uses thereof |
| 10/19/1994 | CN1093598A Use of Il-10 to preventor treat insulin-dependent diabetes mellitus |
| 10/13/1994 | WO1994023050A1 Targeted delivery of genes encoding antisense polyribonucleotides |
| 10/13/1994 | WO1994023048A2 Gibbon ape leukemia virus-based retroviral vectors |
| 10/13/1994 | WO1994023041A2 Method for selective inactivation of viral replication |
| 10/13/1994 | WO1994023031A1 Isolated nucleic acid molecules coding for tumor rejection antigen precursor mage-3 and uses thereof |
| 10/13/1994 | WO1994023028A2 Modified oligonucleotides having improved anti-influenza activity |
| 10/13/1994 | WO1994023015A1 A retroviral vector capable of transducing the aldehyde dehydrogenase-1 gene and uses of said vector |
| 10/13/1994 | WO1994022915A1 Inhibitor of stem cell proliferation and uses thereof |
| 10/13/1994 | WO1994022488A1 ANTISENSE OLIGOS WHICH INTERFERE WITH mRNA CAP ACTIVITY AND INHIBIT TRANSLATION |
| 10/13/1994 | WO1994022487A1 Use of a col 1a1 mini-gene construct to inhibit collagen synthesis |
| 10/13/1994 | WO1994022486A1 Method of inhibiting the proliferation and causing the differentiation of cells with igf-1 receptor antisense oligonucleotides |
| 10/13/1994 | WO1994022475A1 Cloned leptospira outer membrane protein |
| 10/13/1994 | WO1994022468A1 Method for delivering beneficial compositions to hair follicles |
| 10/13/1994 | CA2159916A1 Targeted delivery of genes encoding antisense polyribonucleotides |
| 10/13/1994 | CA2159639A1 Method for selective inactivation of viral replication |
| 10/13/1994 | CA2159506A1 Inhibitor of stem cell proliferation and uses thereof |
| 10/13/1994 | CA2159350A1 Modified oligonucleotides having improved anti-influenza activity |
| 10/13/1994 | CA2159195A1 Use of a col 1a1 mini-gene construct to inhibit collagen synthesis |
| 10/13/1994 | CA2158540A1 Cloned leptospira outer membrane protein |
| 10/13/1994 | CA2158347A1 Method of inhibiting the proliferation and causing the differentiation of cells with igf-1 receptor antisense oligonucleotides |
| 10/13/1994 | CA2135912A1 A retroviral vector capable of transducing the aldehyde dehydrogenase-1 gene and uses of said vector |
| 10/12/1994 | EP0618925A1 Gapped 2' modified oligonucleotides |
| 10/12/1994 | EP0618923A1 Peptide nucleic acids and their effect on genetic material |
| 10/11/1994 | US5354686 Extracellular matrix protein adherent T cells |
| 10/06/1994 | DE4339922C1 Vector for gene therapy of the liver |
| 10/05/1994 | CN1092981A Photosensitizer of traditional herb medicines and its production technology |
| 09/29/1994 | WO1994022014A1 Parvovirus receptors and methods of use |
| 09/29/1994 | WO1994021852A1 Method for performing a seam on various articles, particularly leather articles, and machine that carries out the method |
| 09/29/1994 | WO1994021808A1 Process for preparing cancer vaccines |
| 09/29/1994 | WO1994021806A1 Delivery system controlled through factors associated with hiv and cell |
| 09/29/1994 | WO1994021798A1 Stimulation of immune response by viral protein |
| 09/29/1994 | WO1994021797A1 Nucleic acid pharmaceuticals |
| 09/29/1994 | WO1994021792A2 Inhibition of selected tumor growth with recombinant viral vectors |
| 09/29/1994 | WO1994021781A2 Extracellular signal-regulated kinase, sequences, and methods of production and use |
| 09/29/1994 | WO1994021118A1 Gene-therapy composition and method for treating carcinomas |
| 09/29/1994 | WO1994021115A1 Broad spectrum tumor suppressor genes, gene products and methods for tumor suppression gene therapy |
| 09/29/1994 | WO1994017792A3 Compositions and methods for transdermal drug delivery |
| 09/29/1994 | WO1994011522A3 Vector for the expression of therapy-relevant genes |
| 09/29/1994 | CA2159085A1 Broad spectrum tumor suppressor genes, gene products and methods for tumor suppression gene therapy |
| 09/29/1994 | CA2158655A1 Process for preparing cancer vaccines |
| 09/29/1994 | CA2158564A1 Parvovirus receptors and methods of use |
| 09/29/1994 | CA2158546A1 Inhibition of selected tumor growth with recombinant viral vectors |
| 09/29/1994 | CA2158461A1 Stimulation of immune response by viral protein |
| 09/29/1994 | CA2158252A1 Delivery system controlled through factors associated with hiv and cell |
| 09/28/1994 | EP0617124A1 Immune reactivity to expressed activated oncogenes for diagnosis and treatment of malignancy |
| 09/27/1994 | US5350835 Cellular nucleic acid binding protein and uses thereof in regulating gene expression and in the treatment of aids |
| 09/19/1994 | CA2119175A1 Nucleic acid pharmaceuticals |
| 09/15/1994 | WO1994020641A1 Methods for diagnosis and treatment of xscid |
| 09/15/1994 | WO1994020624A1 Prohormone convertase transformed cells and polypeptide synthesis |
| 09/15/1994 | WO1994020618A1 Genetic suppressor elements associated with sensitivity to chemotherapeutic drugs |
| 09/15/1994 | WO1994020608A1 Improved vectors for gene therapy |
| 09/15/1994 | WO1994020517A1 Gene transfer for treating a connective tissue of a mammalian host |
| 09/15/1994 | WO1994020146A1 Recombinant adenoviruses and use thereof in gene therapy for treating eye diseases |
| 09/15/1994 | WO1994017192A3 Lysosomal targeting of immunogens |
| 09/15/1994 | CA2157931A1 Improved vectors for gene therapy |
| 09/15/1994 | CA2157782A1 Gene transfer for treating a connective tissue of a mammalian host |
| 09/15/1994 | CA2157770A1 Genetic suppressor elements associated with sensitivity to chemotherapeutic drugs |
| 09/15/1994 | CA2154355A1 Recombinant virus and their use in gene therapy |
| 09/14/1994 | EP0614980A1 TAT transdominant variants from human Immunodeficiency virus |
| 09/14/1994 | EP0614486A1 Targeted delivery of virus vector to mammalian cells |
| 09/14/1994 | EP0614374A1 MURINE MONOCLONAL ANTIBODY (5c8) RECOGNIZES A HUMAN GLYCOPROTEIN ON THE SURFACE OF T-LYMPHOCYTES |
| 09/07/1994 | EP0613945A2 Tumor suppressor gene merlin and uses thereof |
| 09/07/1994 | EP0613495A1 Transgenic animals lacking prion proteins |
| 09/01/1994 | WO1994019478A1 Production of high titer helper-free retroviruses by transient transfection |
| 09/01/1994 | WO1994019473A1 Modulators of gene expression |
| 09/01/1994 | WO1994019022A1 Composition for use in the treatment of tumours and the immunization of humans and animals |
| 09/01/1994 | WO1994018992A1 Cytopathic viruses for therapy and prophylaxis of neoplasia |
| 09/01/1994 | WO1994018959A1 Calcium receptor-active molecules |
| 09/01/1994 | WO1994018835A1 Treatment of androgen-associated baldness using antisense oligomers |
| 09/01/1994 | WO1994006449A3 Morphogen-induced liver regeneration |
| 09/01/1994 | WO1994006447A3 60a protein-induced morphogenesis |
| 09/01/1994 | WO1994006420A3 Morphogen treatment of gastrointestinal ulcers |
| 09/01/1994 | WO1993012756A3 Transfection of lung via aerosolized transgene delivery |
| 09/01/1994 | CA2156725A1 Production of high titer helper-free retroviruses by transient transfection |
| 09/01/1994 | CA2156635A1 Composition useful for the treatment of tumors and immunization of organisms against tumors |
| 08/30/1994 | US5342774 Nucleotide sequence encoding the tumor rejection antigen precursor, MAGE-1 |
| 08/26/1994 | CA2115404A1 Tumor suppressor gene merlin and uses thereof |
| 08/24/1994 | EP0611394A1 Cellular nucleic acid binding protein and uses thereof in regulating gene expression and in the treatment of aids |
| 08/18/1994 | WO1994018562A1 Human carcinoma antigen (hca), hca antibodies, hca immunoassays, methods of imaging and therapy |
| 08/18/1994 | WO1994018239A1 Control of cell proliferation |
| 08/18/1994 | WO1994018222A1 Nuclear matrix proteins |
| 08/18/1994 | WO1994017832A1 Targeting and delivery of genes and antiviral agents into cells by the adenovirus penton |
| 08/18/1994 | WO1994017792A2 Compositions and methods for transdermal drug delivery |
| 08/18/1994 | WO1994010203A3 Op-3-induced morphogenesis |
| 08/18/1994 | CA2155645A1 Nuclear matrix proteins |
| 08/18/1994 | CA2154266A1 Human carcinoma antigen (hca), hca antibodies, hca immunoassays, methods of imaging and therapy |
| 08/18/1994 | CA2153243A1 Compositions and methods for transdermal drug delivery |
| 08/17/1994 | EP0610427A1 TGF-$g(b) TYPE RECEPTOR cDNAS AND USES THEREFOR |
| 08/17/1994 | EP0610232A1 Synthetic transfection vectors |
| 08/17/1994 | EP0391960B1 Genetic modification of endothelial cells |
| 08/10/1994 | EP0524997B1 2'-o-alkyl nucleotides and polymers containing them |
| 08/04/1994 | WO1994017196A1 Detection and treatment of mutations in a cd40 ligand gene |
| 08/04/1994 | WO1994017192A2 Lysosomal targeting of immunogens |
| 08/04/1994 | WO1994016737A1 Compositions and methods for delivery of genetic material |
| 08/04/1994 | WO1994016736A1 Localization of therapeutic agents |
| 08/04/1994 | WO1994016718A1 Genetic modification of neural stem cells |
| 08/04/1994 | WO1994016716A1 Recombinant virus immunotherapy |